Abstract
Treating stroke with tissue plasminogen activator (tPA) can help dissolve blood clots and improve outcome. But tPA also increases the risk of hemorrhage and has other deleterious effects. A new approach to treatment minimizes these negative effects.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 993-994 |
| Number of pages | 2 |
| Journal | Nature medicine |
| Volume | 12 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2006 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Taming the clot-buster tPA'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS